[Health] Sanofi draws fire over cost of MS drug Lemtrada

Sanofi draws fire over cost of MS drug Lemtrada
http://www.reuters.com/article/2012/11/01/us-sanofi-lemtrada-lancet-idUSBRE8A000520121101
PARIS (Reuters) - Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators.

Man with thought-controlled bionic leg
http://www.sfgate.com/health/article/Man-with-thought-controlled-bionic-leg-3998896.php
Zac Vawter, fitted with an experimental bionic leg, looks down from the ledge on the Willis Tower in Chicago, where he'll try to climb 103 flights using the new prosthesis.

State to keep Planned Parenthood in program â€" for now
http://houston.cbslocal.com/2012/10/31/planned-parenthood-stays-in-womens-health-program/
AUSTIN - Planned Parenthood will remain part of the Women's Health Program for now, state officials said Wednesday, putting off the organization's ouster as critics questioned whether enough health-care providers would exist without it.

Learning How to Keep Pounds Off
http://www.telegraph.co.uk/health/healthnews/9643114/Weight-maintenance-is-key-to-dieting.html
WEDNESDAY, Oct. 31 (HealthDay News) -- Women who first learn how to maintain their weight regain fewer of the pounds they shed in a weight-loss program, a new study suggests.

As UCLA goes smoke-free, some ask if USC will do the same
http://dailytrojan.com/2012/10/31/as-ucla-goes-smoke-free-some-ask-if-usc-will-do-the-same/
A new smoke-free ban at UCLA, which was announced Tuesday, has re-energized the debate surrounding the implementation of a smoke-free ban on campus at USC.

Seattle Genetics drug OK'd in Europe
http://www.heraldonline.com/2012/10/31/4376930/millennium-and-takeda-announce.html
Seattle Genetics will receive $25 million in milestone payments after its cancer drug Adcetris was granted conditional marketing approval in Europe, the Bothell biotechnology company said Wednesday.